Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

RNA Multi-Omics to Reveal New Targets in Mounting DLBCL and B-ALL Drug Resistance

Nimeree Muntasir, Agin Ravindran, Shafi Mahmud, Merin Joy, Jithmi Perera, Amna Chowdhery, Katrina Woodward, Stefan Prodic, Akanksha Srivastava, Dipti Talaulikar, Eduardo Eyras, Alice Cleynen, Nikolay Shirokikh

Blood (2024) 144 (Supplement 1): 6258.

https://doi.org/10.1182/blood-2024-207810

Published: 2024

Journal Articles

Defining Therapeutic Epitranscriptome of Multiple Myeloma for Accurate Subtyping and Personalized Prognostics

Alice Cleynen, Agin Ravindran, Dipti Talaulikar, Eduardo Eyras, Nikolay Shirokikh

Blood (2024) 144 (Supplement 1): 4652.

https://doi.org/10.1182/blood-2024-204896

Published: 2024

Journal Articles

Frontline R-CHOP and BR Have Similar Outcomes By SUV max in Follicular Lymphoma

Blood (2024) 144 (Supplement 1): 3007.

https://doi.org/10.1182/blood-2024-202088

Published: 2024

Journal Articles

Multiomics Analysis of Paired Diagnosis and Relapse DLBCL Biopsies Shows a Reduction in T Cell Infiltration and Function at Relapse

Fiona Swain, Melinda Burgess, Sarah Kempe, Muhammed B. Sabdia, Andrea S Henden, Joel Wight, Eliza A. Hawkes, Howard Mutsando, Dipti Talaulikar, Lilia Merida de Long, Simone Birch, Penelope Wyche, Zachary Hawula, Rakin Chowdhury, Maher K. Gandhi, Colm Keane

Blood (2024) 144 (Supplement 1): 3006.

https://doi.org/10.1182/blood-2024-199352

Published: 2024

Journal Articles

A High-Throughput Screen Identifies New Drugs for the Treatment of Lymphoma

Dipti Talaulikar, Abhimanu Pandey, Shweta Venkataraman, Dhanvi Vedantham, Si Ming Man

Blood (2023) 142 (Supplement 1): 1437.

https://doi.org/10.1182/blood-2023-179016

Published: 2023

Journal Articles

The Nature of High-Risk Defining Events in Follicular Lymphoma Determines Overall Survival

Blood (2023) 142 (Supplement 1): 1671.

https://doi.org/10.1182/blood-2023-185879

Published: 2023

Journal Articles

Inferior Outcomes for Multiple Myeloma (MM) Patients (pts) Harbouring t(11;14) and the Promise of Venetoclax, Real-World Australian Retrospective

Kenneth JC Lim, Dipti Talaulikar, Joanne L C Tan, Joanna Loh, Pratheepan Puvanakumar, James Anton Kuzich, Michelle Ho, Matthew Murphy, Nicole Zeglinas, Sue Morgan, Michael S.Y. Low, David Routledge, Andrew B M Lim, Simon D. Gibbs, Slavisa Ninkovic

Blood (2021) 138 (Supplement 1): 4752.

https://doi.org/10.1182/blood-2021-145508

Published: 2021

Journal Articles

The NLPHL Tumor Microenvironment Is Markedly Enriched in the Tigit and PD-1 Signalling Axes Compared to Classical Hodgkin Lymphoma

Blood (2021) 138 (Supplement 1): 3513.

https://doi.org/10.1182/blood-2021-145840

Published: 2021

Journal Articles

High-Dose Methotrexate Is Not Associated with Reduction in CNS Relapse in Patients with Aggressive B-Cell Lymphoma: An International Retrospective Study of 2300 High-Risk Patients

Katharine Louise Lewis, Lasse H. Jakobsen, Diego Villa, Sabela Bobillo, Karin Ekstroem Smedby, Kerry J. Savage, Toby A. Eyre, Kate Cwynarski, Paris L Caporn, Joan Van Zyl, Magdalena Klanova, Marek Trněný, Robert Puckrin, Douglas A. Stewart, Mark J Bishton, Christopher P. Fox, Aung M Tun, Gita Thanarajasingam, Faouzi Djebbari, Erel Joffe, Sandra Eloranta, Sara Harrysson, Laurie H. Sehn, Seth M Maliske, Kittika Poonsombudlert, Xiao Guo, Greg Hapgood, Kate Manos, Eliza Hawkes, Jahanzaib Khwaja, Adrian Minson, Michael Dickinson, Andreas Kiesbye Øvlisen, Gareth P Gregory, Michael Gilbertson, Isaac T Streit, Hamish W Scott, Matthew Ku, Sanjay de Mel, Kar Ying Yong, Liu Xin, Mridula Mokoonlall, Dipti Talaulikar, Nicholas L McVilly, Anna Johnston, Matthew J Brunner, Priyanka A Pophali, Matthew J. Maurer, Tarec Christoffer El-Galaly, Chan Yoon Cheah

Blood (2021) 138 (Supplement 1): 181.

https://doi.org/10.1182/blood-2021-146737

Published: 2021

Journal Articles

Real-World Outcomes of Patients with Primary CNS Lymphoma (PCNSL): A Report from the Australasian Lymphoma Alliance (ALA)

Blood (2021) 138 (Supplement 1): 2532.

https://doi.org/10.1182/blood-2021-145959

Published: 2021

Journal Articles

The Genetic Landscape in Elderly DLBCL Aged > 75 Years in the Australasian Leukaemia & Lymphoma Group NHL29 Iric Trial Identifies New Targetable Mutations

Sewa Rijal, Jun Hee Lim, PhD, Lillian Smyth, Caitlin Coombes, MChD, Sanjiv Jain, MBBS, Kartik Saxena, PhD, Judith Trotman, FRACP, Emma Verner, MBBS, FRACP, FRCPA, Maher K. Gandhi, PhDFRACP,FRCPath, Kaushal Gandhi, PhD, Dipti Talaulikar, PhD FRACP, FRCPA, MBBS

Blood (2020) 136 (Supplement 1): 18–20.

https://doi.org/10.1182/blood-2020-141795

Published: 2020

Journal Articles

Somatic Mutations Associated with IgV H 4-34 FR1 Region Unmutated QW and Avy Motifs in DLBCL Patients

Caitlin Coombes, MChD, Keisuke Horikawa, MD PhD, Sanjiv Jain, MBBS, Jun Hee Lim, PhD, Sewa Rijal, Kartik Saxena, PhD, Dipti Talaulikar, PhD FRACP, FRCPA, MBBS

Blood (2020) 136 (Supplement 1): 20–21.

https://doi.org/10.1182/blood-2020-142486

Published: 2020

Journal Articles

Bendamustine Plus Rituximab for the Treatment of Waldenström Macroglobulinaemia: Patient Outcomes and Impact of Bendamustine Dosing

Blood (2020) 136 (Supplement 1): 10–11.

https://doi.org/10.1182/blood-2020-140774

Published: 2020

Journal Articles

Correlation of Hemophagocytosis with Clinical Criteria of Hemophagocytic Lymphohistiocytosis and Recommendations for Screening Bone Marrow Samples in Adult Patients

Caroline Wilson, BS,MBBS, Wei-i Lee, Matthew Cook, Lillian Smyth, Dipti Talaulikar, PhD FRACP, FRCPA, MBBS

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-139246

Published: 2020

Journal Articles

Management and Outcomes of Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder in the PET/CT Era: A Multicentre Study from the Australasian Lymphoma Alliance

Blood (2020) 136 (Supplement 1): 36–38.

https://doi.org/10.1182/blood-2020-140665

Published: 2020

Journal Articles

The 'Real World' Uptake and Prognostic Impact of GELF in Newly Diagnosed Follicular Lymphoma: An Australasian Alliance Initiative

Allison Barraclough, Edward Yoo, Chan Y. Cheah, Dipti Talaulikar, Bianca Nguyen, Michelle Turner, Fatima Tahir, Jing Huang, Colm Keane, MD, Mitchel Lincoln, Tara Cochrane, Anna M. Johnston, Michael Dickinson, MBBS,FRACP,FRCPA, Stephen Opat, Zoe McQuilten, Erica M. Wood, Gayathri St George, Cameron Wellard, Eliza A Hawkes

Blood (2019) 134 (Supplement_1): 3986.

https://doi.org/10.1182/blood-2019-129294

Published: 2019

Journal Articles

B2M Gene Expression Reflects an Immunologically Active Tumor Microenvironment in DLBCL

Clare Gould, Colm Keane, MD, Valentine Murigneux, M.Sc., Harald Oey, Jonathan Ellis, PhD, Simone Birch, MBBS, Jay Gunawardana, PhD, Dipti Talaulikar, Mark S. Hertzberg, MD PhD, Kimberley Jones, Maher K. Gandhi, PhD

Blood (2019) 134 (Supplement_1): 2778.

https://doi.org/10.1182/blood-2019-126537

Published: 2019

Journal Articles

Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study

Jorge J. Castillo, Gilad Itchaki, Jonas Paludo, Marzia Varettoni, Christian Buske, Toby A. Eyre, Julio C. Chavez, Kenneth H. Shain, Samar Issa, M. Lia Palomba, Oren Pasvolsky, David Simpson, Dipti Talaulikar, Constantine S. Tam, Alessandra Tedeschi, Stephen M. Ansell, Lakshmi Nayak, Steven P. Treon

Blood (2019) 133 (4): 299–305.

https://doi.org/10.1182/blood-2018-10-879593

Published: 2019

Journal Articles

Bing Neel Syndrome: Retrospective Australasian Experience of a Rare Treatable Complication of Waldenström Macroglobulinaemia/ Lymphoplasmacytic Lymphoma

Dipti Talaulikar, PhD FRACP, FRCPA, MBBS, Tara Cochrane, MBBS, John Gibson, Nada Hamad, MBBS, BSc, MSc, Phoebe Joy Ho, MBBS DPhil FRACP FRCPA, Samar Issa, FRACP, Kwok Fiona, Jun Hee Lim, PhD, David Simpson, MBChB, FRACP, FRCPA, Constantine Tam, MD PhD, Jorge J. Castillo, MD

Blood (2018) 132 (Supplement 1): 5325.

https://doi.org/10.1182/blood-2018-99-113969

Published: 2018

Journal Articles

Outcomes of Stage I and II Follicular Lymphoma in the Era of 18F-FDG PET-CT Staging: An International Collaborative Study from the Australian Lymphoma Alliance

Blood (2018) 132 (Supplement 1): 4148.

https://doi.org/10.1182/blood-2018-99-114097

Published: 2018

NARROW

RNA Multi-Omics to Reveal New Targets in Mounting DLBCL and B-ALL Drug Resistance

Defining Therapeutic Epitranscriptome of Multiple Myeloma for Accurate Subtyping and Personalized Prognostics

Frontline R-CHOP and BR Have Similar Outcomes By SUV max in Follicular Lymphoma

Multiomics Analysis of Paired Diagnosis and Relapse DLBCL Biopsies Shows a Reduction in T Cell Infiltration and Function at Relapse

A High-Throughput Screen Identifies New Drugs for the Treatment of Lymphoma

The Nature of High-Risk Defining Events in Follicular Lymphoma Determines Overall Survival

Inferior Outcomes for Multiple Myeloma (MM) Patients (pts) Harbouring t(11;14) and the Promise of Venetoclax, Real-World Australian Retrospective

The NLPHL Tumor Microenvironment Is Markedly Enriched in the Tigit and PD-1 Signalling Axes Compared to Classical Hodgkin Lymphoma

High-Dose Methotrexate Is Not Associated with Reduction in CNS Relapse in Patients with Aggressive B-Cell Lymphoma: An International Retrospective Study of 2300 High-Risk Patients

Real-World Outcomes of Patients with Primary CNS Lymphoma (PCNSL): A Report from the Australasian Lymphoma Alliance (ALA)

The Genetic Landscape in Elderly DLBCL Aged > 75 Years in the Australasian Leukaemia & Lymphoma Group NHL29 Iric Trial Identifies New Targetable Mutations

Somatic Mutations Associated with IgV H 4-34 FR1 Region Unmutated QW and Avy Motifs in DLBCL Patients

Bendamustine Plus Rituximab for the Treatment of Waldenström Macroglobulinaemia: Patient Outcomes and Impact of Bendamustine Dosing

Correlation of Hemophagocytosis with Clinical Criteria of Hemophagocytic Lymphohistiocytosis and Recommendations for Screening Bone Marrow Samples in Adult Patients

Management and Outcomes of Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder in the PET/CT Era: A Multicentre Study from the Australasian Lymphoma Alliance

The 'Real World' Uptake and Prognostic Impact of GELF in Newly Diagnosed Follicular Lymphoma: An Australasian Alliance Initiative

B2M Gene Expression Reflects an Immunologically Active Tumor Microenvironment in DLBCL

Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study

Bing Neel Syndrome: Retrospective Australasian Experience of a Rare Treatable Complication of Waldenström Macroglobulinaemia/ Lymphoplasmacytic Lymphoma

Outcomes of Stage I and II Follicular Lymphoma in the Era of 18F-FDG PET-CT Staging: An International Collaborative Study from the Australian Lymphoma Alliance

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only